Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?

Hamed Amani,1,2,* Ebrahim Mostafavi,3,* Mahmoud Reza Alebouyeh,4,* Hamidreza Arzaghi,5 Abolfazl Akbarzadeh,6 Hamidreza Pazoki-Toroudi,7 Thomas J Webster3 1Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran; 2Physiolog...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Amani H, Mostafavi E, Alebouyeh MR, Arzaghi H, Akbarzadeh A, Pazoki-Toroudi H, Webster TJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Targeted Delivery Gold Nanoparticles Necroptosis Surface Charge Oxidative Stress Cytotoxicity Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/ca5d65cff82d43cba554d9e20f60ff14
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ca5d65cff82d43cba554d9e20f60ff14
record_format	dspace
spelling	oai:doaj.org-article:ca5d65cff82d43cba554d9e20f60ff142021-12-02T08:57:27ZWould Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?1178-2013https://doaj.org/article/ca5d65cff82d43cba554d9e20f60ff142019-10-01T00:00:00Zhttps://www.dovepress.com/would-colloidal-gold-nanocarriers-present-an-effective-diagnosis-or-tr-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Hamed Amani,1,2,* Ebrahim Mostafavi,3,* Mahmoud Reza Alebouyeh,4,* Hamidreza Arzaghi,5 Abolfazl Akbarzadeh,6 Hamidreza Pazoki-Toroudi,7 Thomas J Webster3 1Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran; 2Physiology Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran; 3Department of Chemical Engineering, Northeastern University, Boston, MA, USA; 4Anesthesia Department, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran; 5Department of Medical Biotechnology, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran; 6Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; 7Physiology Research Center and Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran*These authors contributed equally to this workCorrespondence: Thomas J WebsterDepartment of Chemical Engineering, Northeastern University, Boston, MA, USAEmail th.webster@neu.eduHamidreza Pazoki-ToroudiPhysiology Research Center and Department of Physiology, Iran University of Medical Sciences, P.O. Box 14515-763, Tehran, IranFax +98-21-88675760Email pazoki49@gmail.comIntroduction: This study was conducted to evaluate OX26-PEG-coated gold nanoparticles (GNPs) (OX26@GNPs) as a novel targeted nanoparticulate system on cell survival after ischemic stroke.Materials and methods: Dynamic light scattering (DLS), zeta sizer, and transmission electron microscopy (TEM) were performed to characterize the OX26@GNPs. The effect of OX26@GNPs on infarct volume, neuronal loss, and necroptosis was evaluated 24 h after reperfusion using 2, 3,5-Triphenyltetrazolium chloride (TTC) staining, Nissl staining and Western blot assay, respectively.Results: Conjugation of OX26-PEG to the surface of the 25 nm colloidal gold particles increased their size to 32±2 nm, while a zeta potential change of −40.4 to 3.40 mV remarkably increased the stability of the nanoparticles. Most importantly, OX26@GNPs significantly increased the infarcted brain tissue, while bare GNPs and PEGylated GNPs had no effect on the infarct volume. However, our results indicated an extension of necroptotic cell death, followed by cell membrane damage.Conclusion: Collectively, our results showed that the presently formulated OX26@GNPs are not suitable nanocarriers nor contrast agents under oxidative stress for the diagnosis and treatment of ischemic stroke. Moreover, our findings suggest that the cytotoxicity of GNPs in the brain is significantly associated with their surface charge.Keywords: targeted delivery, gold nanoparticles, necroptosis, surface charge, oxidative stress, cytotoxicityAmani HMostafavi EAlebouyeh MRArzaghi HAkbarzadeh APazoki-Toroudi HWebster TJDove Medical PressarticleTargeted DeliveryGold NanoparticlesNecroptosisSurface ChargeOxidative StressCytotoxicityMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 8013-8031 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Targeted Delivery Gold Nanoparticles Necroptosis Surface Charge Oxidative Stress Cytotoxicity Medicine (General) R5-920
spellingShingle	Targeted Delivery Gold Nanoparticles Necroptosis Surface Charge Oxidative Stress Cytotoxicity Medicine (General) R5-920 Amani H Mostafavi E Alebouyeh MR Arzaghi H Akbarzadeh A Pazoki-Toroudi H Webster TJ Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?
description	Hamed Amani,1,2,* Ebrahim Mostafavi,3,* Mahmoud Reza Alebouyeh,4,* Hamidreza Arzaghi,5 Abolfazl Akbarzadeh,6 Hamidreza Pazoki-Toroudi,7 Thomas J Webster3 1Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran; 2Physiology Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran; 3Department of Chemical Engineering, Northeastern University, Boston, MA, USA; 4Anesthesia Department, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran; 5Department of Medical Biotechnology, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran; 6Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; 7Physiology Research Center and Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran*These authors contributed equally to this workCorrespondence: Thomas J WebsterDepartment of Chemical Engineering, Northeastern University, Boston, MA, USAEmail th.webster@neu.eduHamidreza Pazoki-ToroudiPhysiology Research Center and Department of Physiology, Iran University of Medical Sciences, P.O. Box 14515-763, Tehran, IranFax +98-21-88675760Email pazoki49@gmail.comIntroduction: This study was conducted to evaluate OX26-PEG-coated gold nanoparticles (GNPs) (OX26@GNPs) as a novel targeted nanoparticulate system on cell survival after ischemic stroke.Materials and methods: Dynamic light scattering (DLS), zeta sizer, and transmission electron microscopy (TEM) were performed to characterize the OX26@GNPs. The effect of OX26@GNPs on infarct volume, neuronal loss, and necroptosis was evaluated 24 h after reperfusion using 2, 3,5-Triphenyltetrazolium chloride (TTC) staining, Nissl staining and Western blot assay, respectively.Results: Conjugation of OX26-PEG to the surface of the 25 nm colloidal gold particles increased their size to 32±2 nm, while a zeta potential change of −40.4 to 3.40 mV remarkably increased the stability of the nanoparticles. Most importantly, OX26@GNPs significantly increased the infarcted brain tissue, while bare GNPs and PEGylated GNPs had no effect on the infarct volume. However, our results indicated an extension of necroptotic cell death, followed by cell membrane damage.Conclusion: Collectively, our results showed that the presently formulated OX26@GNPs are not suitable nanocarriers nor contrast agents under oxidative stress for the diagnosis and treatment of ischemic stroke. Moreover, our findings suggest that the cytotoxicity of GNPs in the brain is significantly associated with their surface charge.Keywords: targeted delivery, gold nanoparticles, necroptosis, surface charge, oxidative stress, cytotoxicity
format	article
author	Amani H Mostafavi E Alebouyeh MR Arzaghi H Akbarzadeh A Pazoki-Toroudi H Webster TJ
author_facet	Amani H Mostafavi E Alebouyeh MR Arzaghi H Akbarzadeh A Pazoki-Toroudi H Webster TJ
author_sort	Amani H
title	Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?
title_short	Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?
title_full	Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?
title_fullStr	Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?
title_full_unstemmed	Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?
title_sort	would colloidal gold nanocarriers present an effective diagnosis or treatment for ischemic stroke?
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/ca5d65cff82d43cba554d9e20f60ff14
work_keys_str_mv	AT amanih wouldcolloidalgoldnanocarrierspresentaneffectivediagnosisortreatmentforischemicstroke AT mostafavie wouldcolloidalgoldnanocarrierspresentaneffectivediagnosisortreatmentforischemicstroke AT alebouyehmr wouldcolloidalgoldnanocarrierspresentaneffectivediagnosisortreatmentforischemicstroke AT arzaghih wouldcolloidalgoldnanocarrierspresentaneffectivediagnosisortreatmentforischemicstroke AT akbarzadeha wouldcolloidalgoldnanocarrierspresentaneffectivediagnosisortreatmentforischemicstroke AT pazokitoroudih wouldcolloidalgoldnanocarrierspresentaneffectivediagnosisortreatmentforischemicstroke AT webstertj wouldcolloidalgoldnanocarrierspresentaneffectivediagnosisortreatmentforischemicstroke
_version_	1718398332121907200

Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?

Ejemplares similares